Annual CFO
-$100.75 M
-$28.28 M-39.03%
31 December 2023
Summary:
Athira Pharma annual cash flow from operations is currently -$100.75 million, with the most recent change of -$28.28 million (-39.03%) on 31 December 2023. During the last 3 years, it has fallen by -$76.64 million (-317.84%). ATHA annual CFO is now -2613.52% below its all-time high of -$3.71 million, reached on 31 December 2019.ATHA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$23.02 M
-$693.00 K-3.10%
30 September 2024
Summary:
Athira Pharma quarterly cash flow from operations is currently -$23.02 million, with the most recent change of -$693.00 thousand (-3.10%) on 30 September 2024. Over the past year, it has increased by +$961.00 thousand (+4.01%). ATHA quarterly CFO is now -1859.40% below its all-time high of -$1.18 million, reached on 31 March 2020.ATHA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$97.45 M
+$961.00 K+0.98%
30 September 2024
Summary:
Athira Pharma TTM cash flow from operations is currently -$97.45 million, with the most recent change of +$961.00 thousand (+0.98%) on 30 September 2024. Over the past year, it has dropped by -$7.32 million (-8.13%). ATHA TTM CFO is now -8193.62% below its all-time high of -$1.18 million, reached on 31 March 2020.ATHA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHA Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.0% | +4.0% | -8.1% |
| 3 y3 years | -317.8% | -123.5% | -173.8% |
| 5 y5 years | -2147.4% | - | - |
ATHA Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -317.8% | at low | -123.5% | +12.4% | -173.8% | +3.3% |
| 5 y | 5 years | -2613.5% | at low | -1859.4% | +12.4% | -8193.6% | +3.3% |
| alltime | all time | -2613.5% | at low | -1859.4% | +12.4% | -8193.6% | +3.3% |
Athira Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$23.02 M(+3.1%) | -$97.45 M(-1.0%) |
| June 2024 | - | -$22.33 M(-13.5%) | -$98.41 M(-1.9%) |
| Mar 2024 | - | -$25.80 M(-1.9%) | -$100.36 M(-0.4%) |
| Dec 2023 | -$100.75 M(+39.0%) | -$26.29 M(+9.6%) | -$100.75 M(+11.8%) |
| Sept 2023 | - | -$23.98 M(-1.2%) | -$90.13 M(+2.7%) |
| June 2023 | - | -$24.28 M(-7.3%) | -$87.78 M(+6.9%) |
| Mar 2023 | - | -$26.19 M(+67.2%) | -$82.09 M(+13.3%) |
| Dec 2022 | -$72.47 M | -$15.67 M(-27.6%) | -$72.47 M(-3.3%) |
| Sept 2022 | - | -$21.64 M(+16.4%) | -$74.98 M(+17.8%) |
| June 2022 | - | -$18.59 M(+12.2%) | -$63.64 M(+21.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$16.57 M(-8.8%) | -$52.37 M(+21.5%) |
| Dec 2021 | -$43.10 M(+78.7%) | -$18.18 M(+76.5%) | -$43.10 M(+21.1%) |
| Sept 2021 | - | -$10.30 M(+40.8%) | -$35.59 M(+2.6%) |
| June 2021 | - | -$7.32 M(+0.2%) | -$34.70 M(+14.7%) |
| Mar 2021 | - | -$7.30 M(-31.5%) | -$30.24 M(+25.4%) |
| Dec 2020 | -$24.11 M(+549.4%) | -$10.66 M(+13.3%) | -$24.11 M(+79.3%) |
| Sept 2020 | - | -$9.41 M(+228.8%) | -$13.45 M(+233.1%) |
| June 2020 | - | -$2.86 M(+143.6%) | -$4.04 M(+243.6%) |
| Mar 2020 | - | -$1.18 M | -$1.18 M |
| Dec 2019 | -$3.71 M(-17.2%) | - | - |
| Dec 2018 | -$4.48 M | - | - |
FAQ
- What is Athira Pharma annual cash flow from operations?
- What is the all time high annual CFO for Athira Pharma?
- What is Athira Pharma annual CFO year-on-year change?
- What is Athira Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Athira Pharma?
- What is Athira Pharma quarterly CFO year-on-year change?
- What is Athira Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for Athira Pharma?
- What is Athira Pharma TTM CFO year-on-year change?
What is Athira Pharma annual cash flow from operations?
The current annual CFO of ATHA is -$100.75 M
What is the all time high annual CFO for Athira Pharma?
Athira Pharma all-time high annual cash flow from operations is -$3.71 M
What is Athira Pharma annual CFO year-on-year change?
Over the past year, ATHA annual cash flow from operations has changed by -$28.28 M (-39.03%)
What is Athira Pharma quarterly cash flow from operations?
The current quarterly CFO of ATHA is -$23.02 M
What is the all time high quarterly CFO for Athira Pharma?
Athira Pharma all-time high quarterly cash flow from operations is -$1.18 M
What is Athira Pharma quarterly CFO year-on-year change?
Over the past year, ATHA quarterly cash flow from operations has changed by +$961.00 K (+4.01%)
What is Athira Pharma TTM cash flow from operations?
The current TTM CFO of ATHA is -$97.45 M
What is the all time high TTM CFO for Athira Pharma?
Athira Pharma all-time high TTM cash flow from operations is -$1.18 M
What is Athira Pharma TTM CFO year-on-year change?
Over the past year, ATHA TTM cash flow from operations has changed by -$7.32 M (-8.13%)